PNC Financial Services Group’s Anixa Biosciences ANIX Stock Holding History

PNC Financial Services Group’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.51K	Hold	3,039	–	–	﹤0.01%	4167
2026 Q1	$7.84K	Hold	3,039	–	–	﹤0.01%	4059
2025 Q4	$9.48K	Hold	3,039	–	–	﹤0.01%	3977
2025 Q3	$10K	Hold	3,039	–	–	﹤0.01%	3936
2025 Q2	$10K	Hold	3,039	–	–	﹤0.01%	3867
2025 Q1	$8.69K	Hold	3,039	–	–	﹤0.01%	3874
2024 Q4	$7.05K	Hold	3,039	–	–	﹤0.01%	3924
2024 Q3	$9.57K	Hold	3,039	–	–	﹤0.01%	3813
2024 Q2	$6.72K	Sell	3,039 -200	-6%	-$567	﹤0.01%	3914
2024 Q1	$10.1K	Buy	3,239 +200	+7%	+$798	﹤0.01%	3741
2023 Q4	$11.8K	Hold	3,039	–	–	﹤0.01%	3665
2023 Q3	$9.94K	Buy	+3,039	New	+$10.6K	﹤0.01%	3762
2019 Q2	–	Sell	-410	Closed	-$2K	–	3999
2019 Q1	$2K	Hold	410	–	–	﹤0.01%	3855
2018 Q4	$2K	Buy	+410	New	+$1.76K	﹤0.01%	3838

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PNC Financial Services Group's ANIX Position: Q2 2026 in Review

PNC Financial Services Group held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 3,039 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

PNC Financial Services Group first reported a position in ANIX in Q4 2018 and has held it in 14 quarters since. The position peaked at $11.8K in Q4 2023. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

PNC Financial Services Group held 3,039 shares of Anixa Biosciences worth $8.51K as of Q2 2026.
PNC Financial Services Group left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4167 holding.
PNC Financial Services Group first reported a position in Anixa Biosciences in Q4 2018 and has held it in 14 quarters since.
PNC Financial Services Group's Anixa Biosciences position peaked at $11.8K in Q4 2023.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.